Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase C (PKC) isoforms and other kinases refers to a broad and heterogeneous group of enzymes rather than a single, specific therapeutic target. The PKC family consists of multiple serine/threonine kinases—classified into conventional, novel, and atypical subfamilies—that play pivotal roles in signal transduction pathways regulating cell growth, differentiation, and survival [1]. In drug discovery, this terminology is frequently used to describe the off-target profile or broad selectivity of multi-kinase inhibitors, such as staurosporine derivatives, which may interact with various members of the kinome beyond their primary target [2, 3]. While individual PKC isoforms are investigated as targets for cancer, diabetic complications, and inflammatory diseases, the simultaneous inhibition of other kinases often leads to significant toxicity}
Inhibition of kinase catalytic activity through ATP-competitive binding or modulation of regulatory domains.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C isoforms and other kinases (PKC and other kinases).